The effect of cancer treatment and anaesthesia on your heart.

The Cardio-toxicity of Cancer Chemotherapy And Anaesthesia - A Prospective Observational Study - none

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2020/10/028628

Enrollment

Registered

2020-10-26

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: D499- Neoplasm of unspecified behavior of unspecified site

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: - Patients who have received cardiotoxic cancer chemotherapy - Patients more than 18 years - Patients of either sex - ASA physical status I and II - Patients posted for elective surgery

Exclusion criteria

Exclusion criteria: - Patients with post radiotherapy - Patients who have received non cardiotoxic cancer chemotherapy - ASA physical status III and IV - Patients with pre-existing cardiac diseases

Design outcomes

Primary

Measure	Time frame
- Preoperative MET level - Preoperative chest x-ray findings - Preoperative ECG findings - Preoperative echogardiography findingsTimepoint: Preoperative	—

Secondary

Measure	Time frame
- Postoperative MET level - Postoperative chest x-ray findings - Postoperative ECG finding - Postoperative echocardiology findingsTimepoint: Postoperative	—

Countries

India

Contacts

Public ContactDr Rajani Thabah

North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences

rajanithabah@yahoo.com9485098914

Outcome results